Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Veerman

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
British Journal of Cancer|June 11, 1999
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.
Seminars in Oncology|October 1, 1996
Preclinical combination therapy with gemcitabine and mechanisms of resistanceG J Peters, V W Ruiz van Haperen, A M Bergman, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC)J R Kroep, C J van Moorsel, G Veerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies GroupE Briasoulis, I Judson, N Pavlidis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumoursC J van Moorsel, H M Pinedo, K Smid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumorsC J van Moorsel, J R Kroep, H M Pinedo, et al.
Cancer Research|April 28, 2001
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitorsC L van der Wilt, H H Backus, K Smid, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
British Journal of Cancer|June 11, 1999
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.
Seminars in Oncology|October 1, 1996
Preclinical combination therapy with gemcitabine and mechanisms of resistanceG J Peters, V W Ruiz van Haperen, A M Bergman, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC)J R Kroep, C J van Moorsel, G Veerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies GroupE Briasoulis, I Judson, N Pavlidis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumoursC J van Moorsel, H M Pinedo, K Smid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumorsC J van Moorsel, J R Kroep, H M Pinedo, et al.
Cancer Research|April 28, 2001
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitorsC L van der Wilt, H H Backus, K Smid, et al.
Pageof 4